NIH-funded research R01 grant

Understanding how FAM210A affects heart health

Official title: Deciphering the role of FAM210A in cardiac physiopathology

Funded at University of Rochester · NIH-10895589 · Data updated 2026-11-12

This study is looking at how a gene called FAM210A affects heart health, especially in conditions like heart muscle disease and heart attacks, to help find new ways to treat these issues for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startAugust 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$475,960
NIH project number5R01HL169432-02
Project IDNIH-10895589 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who have been diagnosed with cardiac diseases or conditions related to mitochondrial dysfunction.

Less likely to help

Patients with non-cardiac related health issues or those under 21 years old may not receive any benefit from this research.

What this research studies

This research investigates the role of a specific gene, FAM210A, in heart diseases, particularly focusing on how it influences mitochondrial function in heart cells. By using advanced techniques like CRISPR, the study aims to explore the molecular mechanisms that lead to heart conditions such as mitochondrial cardiomyopathy and myocardial infarction. The researchers will analyze how changes in FAM210A expression affect heart cell health and function, which could lead to new therapeutic strategies for heart disease. Patients may benefit from insights gained about the genetic factors contributing to their heart conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for heart diseases by targeting the molecular pathways involved in cardiac dysfunction.

How similar studies have gone: Previous research has shown promising results in understanding mitochondrial dysfunction in heart diseases, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Yao, Peng — University of Rochester
  • Study coordinator: Yao, Peng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.